These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 7579468

  • 1. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient.
    Spencer A, Szydlo RM, Brookes PA, Kaminski E, Rule S, van Rhee F, Ward KN, Hale G, Waldmann H, Hows JM, Batchelor JR, Goldman JM.
    Blood; 1995 Nov 01; 86(9):3590-7. PubMed ID: 7579468
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA, Passweg J, Kawanishi Y, Casper J, Flomenberg N, Baxter-Lowe LA.
    Bone Marrow Transplant; 1997 May 01; 19(10):1001-9. PubMed ID: 9169644
    [Abstract] [Full Text] [Related]

  • 4. T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.
    Drobyski WR, Hessner MJ, Klein JP, Kabler-Babbitt C, Vesole DH, Margolis DA, Keever-Taylor CA.
    Blood; 1999 Jul 15; 94(2):434-41. PubMed ID: 10397710
    [Abstract] [Full Text] [Related]

  • 5. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.
    Davies SM, DeFor TE, McGlave PB, Miller JS, Verfaillie CM, Wagner JE, Weisdorf DJ.
    Am J Med; 2001 Apr 01; 110(5):339-46. PubMed ID: 11286947
    [Abstract] [Full Text] [Related]

  • 6. Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia.
    Hessner MJ, Endean DJ, Casper JT, Horowitz MM, Keever-Taylor CA, Roth M, Flomenberg N, Drobyski WR.
    Blood; 1995 Nov 15; 86(10):3987-96. PubMed ID: 7579370
    [Abstract] [Full Text] [Related]

  • 7. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.
    Petersdorf EW, Kollman C, Hurley CK, Dupont B, Nademanee A, Begovich AB, Weisdorf D, McGlave P.
    Blood; 2001 Nov 15; 98(10):2922-9. PubMed ID: 11698272
    [Abstract] [Full Text] [Related]

  • 8. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR.
    Biol Blood Marrow Transplant; 2001 Nov 15; 7(11):620-30. PubMed ID: 11760150
    [Abstract] [Full Text] [Related]

  • 9. Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia.
    Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F.
    Blood; 1994 Apr 01; 83(7):1980-7. PubMed ID: 8142664
    [Abstract] [Full Text] [Related]

  • 10. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Devergie A, Apperley JF, Labopin M, Madrigal A, Jacobsen N, Carreras E, Prentice HG, Jouet JP, Kolb HJ, Herstenstein B, Bacigalupo A, Evensen SA, Ljungman P, de Witte T, Reiffers J, Nagler A, Clark RE, Goldman JM, Gratwohl A.
    Bone Marrow Transplant; 1997 Jul 01; 20(1):11-9. PubMed ID: 9232250
    [Abstract] [Full Text] [Related]

  • 11. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr 01; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 12. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.
    Woolfrey A, Klein JP, Haagenson M, Spellman S, Petersdorf E, Oudshoorn M, Gajewski J, Hale GA, Horan J, Battiwalla M, Marino SR, Setterholm M, Ringden O, Hurley C, Flomenberg N, Anasetti C, Fernandez-Vina M, Lee SJ.
    Biol Blood Marrow Transplant; 2011 Jun 01; 17(6):885-92. PubMed ID: 20870028
    [Abstract] [Full Text] [Related]

  • 13. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
    El Kassar N, Legouvello S, Joseph CM, Salesses P, Rieux C, Cordonnier C, Vernant JP, Farcet JP, Bierling P, Kuentz M.
    Bone Marrow Transplant; 2001 Jan 01; 27(1):35-43. PubMed ID: 11244436
    [Abstract] [Full Text] [Related]

  • 14. Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program.
    McGlave P, Bartsch G, Anasetti C, Ash R, Beatty P, Gajewski J, Kernan NA.
    Blood; 1993 Jan 15; 81(2):543-50. PubMed ID: 8422471
    [Abstract] [Full Text] [Related]

  • 15. HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.
    Arora M, Weisdorf DJ, Spellman SR, Haagenson MD, Klein JP, Hurley CK, Selby GB, Antin JH, Kernan NA, Kollman C, Nademanee A, McGlave P, Horowitz MM, Petersdorf EW.
    J Clin Oncol; 2009 Apr 01; 27(10):1644-52. PubMed ID: 19224849
    [Abstract] [Full Text] [Related]

  • 16. Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective.
    Enright H, Davies SM, DeFor T, Shu X, Weisdorf D, Miller W, Ramsay NK, Arthur D, Verfaillie C, Miller J, Kersey J, McGlave P.
    Blood; 1996 Jul 15; 88(2):714-20. PubMed ID: 8695820
    [Abstract] [Full Text] [Related]

  • 17. Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome.
    Green A, Clarke E, Hunt L, Canterbury A, Lankester A, Hale G, Waldmann H, Goodman S, Cornish JM, Marks DI, Steward CG, Oakhill A, Pamphilon DH.
    Blood; 1999 Oct 01; 94(7):2236-46. PubMed ID: 10498594
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J, Martin PJ, Longton G, Masewicz S, Mickelson E, Petersdorf E, Anasetti C, Hansen J.
    Biol Blood Marrow Transplant; 1997 Aug 01; 3(3):142-9. PubMed ID: 9310191
    [Abstract] [Full Text] [Related]

  • 19. Pretransplant cytotoxic donor T-cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT.
    Speiser DE, Löliger CC, Siren MK, Jeannet M.
    Br J Haematol; 1996 Jun 01; 93(4):935-9. PubMed ID: 8703829
    [Abstract] [Full Text] [Related]

  • 20. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T, Van Lint MT, Gualandi F, Occhini D, Barbanti M, Sacchi N, Ficai G, Ghinatti C, Ferrara GB, Delfino L, Pozzi S, Morabito A, Zikos P, Vitale V, Corvo R, Frassoni F, Bacigalupo A.
    Bone Marrow Transplant; 1997 Dec 01; 20(12):1057-62. PubMed ID: 9466278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.